Open Access
Article
Apigenin induces apoptosis and impairs head and neck carcinomas EGFR/ErbB2 signaling
Laura Masuelli1,Laura Marzocchella1,Alessandro Quaranta1,Camilla Palumbo1,Giorgio Pompa1,Valerio Izzi1,Antonella Canini1,Andrea Modesti1,Fabio Galvano1,Roberto Bei1
1
Department of Experimental Medicine, University of Rome, Sapienza, Rome, Italy
DOI: 10.2741/3735 Volume 16 Issue 3, pp.1060-1068
Published: 01 January 2011
(This article belongs to the Special Issue Dietary approaches to prevent chronic-degenerative diseases)
Abstract

The development of head and neck squamous cell carcinomas (HNSCCs) is a multistep process progressing from precancerous lesions to highly malignant tumors. A critical role in HNSCCs development and progression is played by EGFR family members including EGFR and ErbB2. The aim of this study was to investigate the effect of apigenin, a low molecular weight flavonoid contained in fruits and vegetables, on growth and survival and on EGFR/ErbB2 signaling in cell lines derived from HNSCCs of the tongue (CAL-27, SCC-15) or pharynx (FaDu). Using sulforhodamine B assay, FACS analysis and activated caspase-3 detection by immunofluorescence, we here demonstrate that apigenin dose-dependently inhibits survival and induces apoptosis of HNSCC cells. Further, by performing western blotting with antibodies specific for phosphorylated EGFR, ErbB2, Erk1/2 and Akt we demonstrate that apigenin reduces ligand-induced phosphorylation of EGFR and ErbB2 and impairs their downstream signaling. On the whole, our results suggest that apigenin properties might be exploited for chemoprevention and/or therapy of head and neck carcinomas.

Share and Cite
Laura Masuelli, Laura Marzocchella, Alessandro Quaranta, Camilla Palumbo, Giorgio Pompa, Valerio Izzi, Antonella Canini, Andrea Modesti, Fabio Galvano, Roberto Bei. Apigenin induces apoptosis and impairs head and neck carcinomas EGFR/ErbB2 signaling. Frontiers in Bioscience-Landmark. 2011. 16(3); 1060-1068.